Abstracts tagged "patient engagement and rheumatoid arthritis (RA)"

Abstract Number: 1925 • 2018 ACR/ARHP Annual Meeting
Goal Concordance in Rheumatoid Arthritis: Beyond Pain Reduction, Is There Agreement?
Jennifer Barton^1,2, Shelia Markwardt², Allison Schue¹, Somnath Saha^2,3 and Edward H. Yelin⁴, ¹VA Portland Health Care System, Portland, OR, ²Oregon Health & Science University, Portland, OR, ³Medicine, VA Portland Health Care System, Portland, OR, ⁴Medicine/Rheumatology, University of California San Francisco, San Francisco, CA
Background/Purpose: Goal concordance between patients with chronic diseases and their clinicians has been linked to improved outcomes, but not explored in rheumatoid arthritis (RA). Our…
Abstract Number: 216 • 2017 ACR/ARHP Annual Meeting
Creation of the First Massive Open Online Course for Patients with Rheumatoid Arthritis
Sonia Tropé¹, Jean-David Cohen², Catherine Beauvais³, Didier Poivret⁴, Alain Saraux⁵, Danielle VACHER⁶, Hervé Barkatz⁷, Pascal Lacoste⁷, Valérie Weill⁸ and Gérard Thibaud⁹, ¹149 avenue du Maine, ANDAR, Paris, France, ²IMMUNO-RHEUMATOLOGY, CHU LAPEYRONIE, MONTPELLIER, France, ³Service de Rhumatologie, Hopital Saint Antoine, Paris, France, ⁴Rheumatology, Metz, France, ⁵Rheumatology, Brest University Medical School Hospital, Brest, France, ⁶expert-patient, ANDAR patient organisation, Paris, France, ⁷Hbmotion, Paris, France, ⁸hbmotion, Paris, France, ⁹ANDAR patient organisation, Paris, France
Background/Purpose: People with chronic conditions face the disease more effectively when they develop psychosocial skills and self-care. Health authorities thus recommend the organization of therapeutic…
Abstract Number: 2255 • 2017 ACR/ARHP Annual Meeting
Using PROs to Guide Patient-Centered Conversations and Care in Inflammatory Arthritis: The Patient Perspective
Clifton O. Bingham III¹, Katherine Clegg Smith², Elaine de Leon², Michelle Jones³, Anna Kristina Gutierrez⁴, Allie Butanis⁵ and Susan J. Bartlett⁴, ¹Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ²Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, ³Johns Hopkins University School of Medicine, Baltimore, MD, ⁴Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ⁵Rheumatology, Johns Hopkins School of Medicine, Baltimore, MD
Background/Purpose: Although optimal care is patient-centered and grounded in shared decision-making (SDM) between patients and providers, rheumatologists often have little insight into the day-to-day experiences…
Abstract Number: 2780 • 2017 ACR/ARHP Annual Meeting
Preference Phenotypes Can be Used to Support Shared Decision Making at the Point-of-Care
Liana Fraenkel¹, Pauline Binder-Finnema², Betty Hsiao², Carole Wiedmeyer³, George Michel² and W. Benjamin Nowell⁴, ¹Rheumatology, Rheumatology, Yale University School of Medicine, New Haven, CT, New Haven, CT, ²Yale University School of Medicine, New Haven, CT, ³CreakyJoints/Global Health Living Foundation, Upper Nyack, NY, ⁴Global Healthy Living Foundation, Upper Nyack, NY
Background/Purpose: Many important treatment decisions for patients with rheumatoid arthritis (RA) are conditional on patient preferences and mandate a shared decision making (SDM) approach. Furthermore,…
Abstract Number: 91 • 2016 ACR/ARHP Annual Meeting
A Systematic Review of Smartphone Applications for Measuring and Recording Rheumatoid Arthritis Disease Activity
Rebecca Grainger^1,2, Hermaleigh Townsley³, Bonnie White⁴, Tobias Langlotz⁵ and William Taylor^1,6, ¹University of Otago Wellington, Wellington, New Zealand, ²Wellington Regional Rheumatology Unit, Hutt Valley District Health Board, Lower Hutt, New Zealand, ³Department of Medicine, University of Otago Wellington, Wellington, New Zealand, ⁴Department of Medicine, University of Otago Wellington, Wellington South, New Zealand, ⁵Department of Information Science, University of Otago, Dunedin, New Zealand, ⁶Wellington Regional Rheumatology Unit, Hutt Valley District Health Board, Wellington, New Zealand
Background/Purpose: It is recommended that management of rheumatoid arthritis (RA) requires regular quantitative assessment of RA activity. Treat to target management could be facilitated by use…
Abstract Number: 541 • 2016 ACR/ARHP Annual Meeting
Patient Goals in Rheumatoid Arthritis Care: A Literature Review
Elizabeth Hulen¹, Ayla Ervin¹, Allison Schue¹, Gina Evans-Young², Somnath Saha^3,4, Edward H. Yelin⁵ and Jennifer Barton^1,4, ¹VA Portland Health Care System, Portland, OR, ²Rheumatology, UCSF, San Francisco, CA, ³Medicine, VA Portland Health Care System, Portland, OR, ⁴Oregon Health & Science University, Portland, OR, ⁵Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA
Background/Purpose: While clinician goals when treating rheumatoid arthritis (RA) focus on achieving low disease activity or remission, RA patient goals remain largely unexplored. Patient-clinician goal…
Abstract Number: 2469 • 2016 ACR/ARHP Annual Meeting
How Rheumatoid Arthritis Patients and Rheumatologists Communicate during Clinic Visits When a New DMARD Is Prescribed
Lorie L. Geryk¹, Susan J. Blalock², Courtney A. Roberts², Beth L. Jonas³ and Delesha M. Carpenter⁴, ¹Division of Pharmaceutical Outcomes and Policy, University of North Carolina, Chapel Hill, NC, ²Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, ³Thurston Arthritis Research Ct, University of North Carolina Thruston Arthritis Research Center, Chapel Hill, NC, ⁴Division of Pharmaceutical Outcomes and Policy, University of North Carolina, Asheville, NC
Background/Purpose: This observational study includes data from clinic visits of 38 RA patients (3 rheumatologists) that occurred in a southeastern state from May 2014 to…
Abstract Number: 452 • 2015 ACR/ARHP Annual Meeting
Associations Between Arthritis Patient, Disease-Specific and Provider Characteristics and Medication Information Source Use
Lorie Geryk¹, Susan J. Blalock², Robert DeVellis³, Joanne M. Jordan³ and Delesha Carpenter⁴, ¹Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, ²Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, ³Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, ⁴Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Asheville, NC
Background/Purpose: Few studies have described how patient, disease-specific, and provider factors are associated with medication information source use among arthritis patients. We address this research…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].